Filing Flows

Filing Flows › Companies › Glaukos › Cash flow

Glaukos cash flow, quarter by quarter

Latest: Q3 2026 · from the cash-flow statements filed with the SEC

Free cash flow$36.5M in Q3 2026 · $36.0M over twelve months

Operating cash flow$38.6M
Capital spending−$2.1M
Free cash flow+$36.5M
Cash / net income19.1×
Cash conversion cycle176 days

Analysis

In Q3 2026, Glaukos generated $38.6M of operating cash flow and spent $2.1M on capital projects, leaving free cash flow of $36.5M. That is $48.2M more than in Q3 2025 (−$11.7M).

Over the twelve months to Sep 30, 2026, operating cash flow was $47.7M; the largest uses were capital spending ($11.7M), taxes on employees’ shares ($8.6M), other investing ($4.5M); besides operations, cash came from shares issued ($36.5M), other financing ($7.3M); the cash balance rose by $63.4M.

Operating cash flow was $38.6M against net income of $2.0M — 19.1× profit, cash ran ahead of reported earnings. The largest differences: stock-based pay +$17.8M, receivables −$9.9M, payables +$9.5M.

Its cash conversion cycle was 176 days (receivables 63 + inventory 178 − payables 64).

Free cash flow

Glaukos: free cash flow by quarterGlaukos: free cash flow by quarter−$1.2MQ4 2024−$20.5MQ1 2025$5.8MQ2 2025−$11.7MQ3 2025$3.9MQ4 2025−$16.5MQ1 2026$12.1MQ2 2026$36.5MQ3 2026
Operating cash flow less capital spending.
Glaukos: operating cash flow against capital spendingGlaukos: operating cash flow against capital spendingOperating cash flowCapital spending$507K$1.7MQ4 2024−$18.5M$1.9MQ1 2025$7.0M$1.2MQ2 2025−$10.1M$1.6MQ3 2025$6.8M$2.9MQ4 2025−$12.5M$4.0MQ1 2026$14.8M$2.7MQ2 2026$38.6M$2.1MQ3 2026
Latest (Q3 2026): Operating cash flow $38.6M, Capital spending $2.1M.

Capital allocation, year by year

Glaukos: where the cash came from (up) and went (down), by fiscal yearGlaukos: where the cash came from (up) and went (down), by fiscal yearOperating cash flowNet borrowingShares issuedAsset salesCapital spendingAcquisitionsFY2021: Operating cash flow $24.7MFY2021: Net borrowing −$659KFY2021: Shares issued $26.1MFY2021: Asset sales $3KFY2021: Capital spending −$47.8M$50.8MFY2021FY2022: Operating cash flow −$33.1MFY2022: Net borrowing −$527KFY2022: Shares issued $3.6MFY2022: Asset sales $151KFY2022: Capital spending −$30.3M$3.7MFY2022FY2023: Operating cash flow −$57.8MFY2023: Net borrowing −$711KFY2023: Shares issued $12.7MFY2023: Capital spending −$20.2M$12.7MFY2023FY2024: Operating cash flow −$61.3MFY2024: Net borrowing $52.3MFY2024: Shares issued $39.3MFY2024: Asset sales $38KFY2024: Capital spending −$6.3M$91.7MFY2024FY2025: Operating cash flow −$14.8MFY2025: Net borrowing −$1.1MFY2025: Shares issued $13.5MFY2025: Capital spending −$7.7MFY2025: Acquisitions −$12.4M$13.5MFY2025
Over these 5 years operating cash flow totalled −$142M; the largest uses were operating cash flow ($167M) and capital spending ($112M). Cash-flow statements as filed.

Cash runway and the debt wall

Cash & investments$162M
Debtnone
Net cash$162M

Glaukos funds itself: free cash flow was $36.0M over the last twelve months, with $162M of cash and investments and no debt on the balance sheet.

Where the cash came from and went

Glaukos: sources (+) and uses (−) of cash, Q3 2026Glaukos: sources (+) and uses (−) of cash, Q3 2026Cash drawn (+) / kept (−)−$47.8MOperating cash flow$38.6MShares issued$10.2MOther financing$4.9MOther investing−$3.5MCapital spending−$2.1MNet borrowing (+) / repaid (−)−$355KExchange rates$128K
Glaukos: sources (+) and uses (−) of cash, TTM to Q3 2026Glaukos: sources (+) and uses (−) of cash, TTM to Q3 2026Cash drawn (+) / kept (−)−$63.4MOperating cash flow$47.7MShares issued$36.5MCapital spending−$11.7MTaxes on employees’ shares−$8.6MOther financing$7.3MOther investing−$4.5MExchange rates−$2.0MNet borrowing (+) / repaid (−)−$1.3M

From profit to cash

Glaukos: net income to operating cash flow, Q3 2026Glaukos: net income to operating cash flow, Q3 2026Net income$2.0MDepreciation & amortization$9.0MStock-based pay$17.8MGains on disposals$173KReceivables−$9.9MInventory−$1.9MPayables$9.5MOperating cash flow$38.6M
Non-cash charges are added back; money tied up in receivables or inventory is subtracted.
QuarterReceivable daysInventory daysPayable daysCash conversion cycle
Q3 20266317864176
Q2 20266316351175
Q1 20266817059179
Q4 20256718464187
Q3 20256320554214
Q2 20255721050217
Q1 20255621753219
Q4 20245118939201

Every quarter

QuarterOperating cash flowCapital spendingNet borrowing (+) / repaid (−)Shares issuedCash drawn (+) / kept (−)Free cash flow
Q3 2026$38.6M−$2.1M−$355K$10.2M−$47.8M$36.5M
Q2 2026$14.8M−$2.7M−$336K$4.1M−$9.5M$12.1M
Q1 2026−$12.5M−$4.0M−$304K$19.3M−$13.4M−$16.5M
Q4 2025$6.8M−$2.9M−$300K$2.9M$7.4M$3.9M
Q3 2025−$10.1M−$1.6M−$295K$1.5M$2.6M−$11.7M
Q2 2025$7.0M−$1.2M−$278K$5.0M$14.3M$5.8M
Q1 2025−$18.5M−$1.9M−$248K$4.1M$55.4M−$20.5M
Q4 2024$507K−$1.7M−$212K$9.8M−$69.5M−$1.2M

Glaukos: income statement and cash flow

Glaukos, Q3 2026: revenue $211M (+58% year over year), operating margin 0.4%. The chart follows the revenue to costs, profit and cash.

Glaukos: every quarter, Q/Q and Y/Y → Open in the app

Read automatically from the company’s XBRL cash-flow statements; quarterly figures for the fourth quarter are the year less the first three. Errors are possible. Not investment advice.